IQVIA Holdings | IQV - Pasivo Circulante

Precio De Mercado
162.28
Cambio Diario
1.60 1.00%
Mensual
-2.03%
Anual
7.99%
Q2 Expectativa
172.58




Pasivo Circulante Cambio Fecha
Accenture USD 20.96B 1.06B 2025-12
Agilent USD 2.23B 113M 2025-12
Bruker USD 1.28B 11.1M 2025-12
Cardinal Health USD 43.31B 3.05B 2025-12
Celltrion KRW 4.01T 343.96B 2025-09
Charles River Laboratories USD 1.12B 1.57M 2025-12
Cigna USD 56.34B 111M 2025-12
Cognizant Technology Solutions USD 3.66B 226M 2025-12
Computer Programs Systems USD 57.96M 4.21M 2025-12
Cspc Pharmaceutical CNY 10.18B 65.36M 2025-12
CVS Health USD 88.69B 4B 2025-12
Danaher USD 7.46B 653M 2026-03
Dentsply International USD 1.34B 62M 2025-12
Deva Holding AS TRY 6.43B 1.18B 2023-09
Dianthus Therapeutics USD 30.73M 6.88M 2025-12
Divis Laboratories Ltd INR 17.28B 2.76B 2025-09
Elevance Health USD 45.31B 4.27B 2026-03
Humana USD 16.35B 166M 2025-12
IBM USD 40.1B 1.44B 2026-03
Illumina USD 1.59B 377M 2025-12
Infosys INR 499.34B 35.36B 2025-12
Kangmei Pharma CNY 5.81B 57.93M 2025-09
Knight Therapeutics CAD 165.26M 12.58M 2025-12
Laboratorios Farma EUR 199.84M 121.75M 2023-12
Laboratory Of America USD 2.82B 194.3M 2025-12
Malin Corporation EUR 1000K 500K 2024-12
McKesson USD 68.13B 100M 2025-12
Mettler Toledo International USD 1.2B 5.99M 2025-12
Organigram Holdings CAD 94.05M 32.11M 2025-12
Ovoca Bio EUR 186K 2.26M 2025-06
Pharma Mar EUR 93.88M 4.94M 2025-12
Publicis EUR 23.89B 3.02B 2025-12
Qiagen NV USD 512.14M 461.26M 2025-12
Quest Diagnostics USD 2.18B 101M 2026-03
Revvity USD 1.33B 108.5M 2025-12
Sartorius EUR 2.11B 145.8M 2026-03
Sino Biopharmaceutical CNY 24.85B 5.29B 2025-06
Thermo Fisher Scientific USD 14.62B 568M 2026-03
Tilray USD 259.32M 8.32M 2025-09
UnitedHealth USD 114.9B 629M 2025-12
Veeva Systems USD 1.64B 692.18M 2025-12
Veradigm USD 230.31M 22.78M 2022-12
Waters USD 1.24B 11.8M 2025-12
Zealand Pharma A/S 664.96M 513.61M 2025-12
Zz Pientze Pharmaceu CNY 2.14B 1.06B 2025-09